Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 16/74 ]
NASDAQ | Common Stock
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.
The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
It markets its products through a single direct sales force, principally in the United States.
TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 26 | -0.21 Increased by +14.24% | -0.15 Decreased by -39.86% |
| Mar 24, 26 | -0.17 Increased by +26.09% | -0.18 Increased by +5.56% |
| Nov 13, 25 | -0.19 Increased by +54.76% | -0.20 Increased by +5.00% |
| Aug 11, 25 | -0.22 Increased by +56.86% | -0.18 Decreased by -22.22% |
| May 8, 25 | -0.25 Increased by +53.70% | -0.21 Decreased by -19.05% |
| Mar 19, 25 | -0.23 Increased by +56.60% | -0.22 Decreased by -3.60% |
| Nov 7, 24 | -0.42 Increased by +6.67% | -0.42 |
| Aug 12, 24 | -0.51 Decreased by -10.87% | -0.47 Decreased by -8.51% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 19.06 M Increased by +2.91% | -12.27 M Decreased by -8.96% | Decreased by -64.39% Decreased by -5.88% |
| Dec 31, 25 | 20.87 M Increased by +18.24% | -9.04 M Increased by +1.81% | Decreased by -43.32% Increased by +16.96% |
| Sep 30, 25 | 20.69 M Increased by +9.14% | -8.60 M Increased by +17.06% | Decreased by -41.58% Increased by +24.00% |
| Jun 30, 25 | 20.20 M Increased by +25.52% | -9.92 M Increased by +21.25% | Decreased by -49.13% Increased by +37.26% |
| Mar 31, 25 | 18.52 M Increased by +11.55% | -11.26 M Decreased by -98.98% | Decreased by -60.82% Decreased by -78.38% |
| Dec 31, 24 | 17.65 M Increased by +3.83% | -9.21 M Increased by +28.56% | Decreased by -52.17% Increased by +31.20% |
| Sep 30, 24 | 18.96 M Increased by +25.94% | -10.37 M Increased by +5.34% | Decreased by -54.71% Increased by +24.84% |
| Jun 30, 24 | 16.09 M Increased by +11.02% | -12.60 M Decreased by -16.77% | Decreased by -78.30% Decreased by -5.19% |